SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General Statement of Acquisition of Beneficial Ownership:
SEC Accession No. 0001193125-18-316377
Filing Date
2018-11-02
Accepted
2018-11-02 07:33:35
Documents
4
Group Members
VIFOR FRESENIUS MEDICAL CARE RENAL PHARMA LTD.VIFOR PHARMA LTD.

Document Format Files

Seq Description Document Type Size
1 SC 13D d620846dsc13d.htm SC 13D 80920
2 EX-99.1 d620846dex991.htm EX-99.1 10060
3 EX-99.2 d620846dex992.htm EX-99.2 61013
4 EX-99.3 d620846dex993.htm EX-99.3 31673
  Complete submission text file 0001193125-18-316377.txt   185184
Mailing Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043
Business Address 850 MAUDE AVENUE MOUNTAIN VIEW CA 94043 650-210-2900
ChemoCentryx, Inc. (Subject) CIK: 0001340652 (see all company filings)

IRS No.: 943254365 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-86723 | Film No.: 181155507
SIC: 2834 Pharmaceutical Preparations

Mailing Address RECHENSTRASSE 37 ST. GALLEN V8 9000
Business Address RECHENSTRASSE 37 ST. GALLEN V8 9000 41 58 851 80 00
Vifor (International) Ltd (Filed by) CIK: 0001675217 (see all company filings)

IRS No.: 000000000 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: SC 13D